Tell your doctor and pharmacist about all medicines your child takes
In generalized anxiety disorder and panic disorder, for instance, those with mild symptoms derive little benefit from antidepressant treatment, and potential harm may outweigh benefits
The cardiovascular safety of GLP-1based medicines was first demonstrated in T2D in 2016, and in people with obesity in 2023
Quality Control Problems Some online products may contain: Without independent laboratory verification, buyers often rely entirely on trust
The evidence is promising, but it is preclinical
Patients should maintain realistic expectations and continue treatment as prescribed, even if immediate improvements are not apparent, as premature discontinuation can lead to symptom recurrence